NBHC vs QFIN

NBHC presents a contradictory profile characterized by a very weak Piotroski F-Score of 2/9, indicating significant deterioration in fundamental financial health. While the stock trades below its Graham Number ($47.02), suggesting defensive value, it is priced far above its growth-based intrinsic value ($18.76). Strong top-line revenue growth (33.7%) is currently offset by a sharp decline in earnings growth (-27%), creating a divergence between scale and profitability. Despite bullish analyst targets, the combination of poor health scores, bearish insider sentiment, and negative earnings momentum warrants a cautious approach.

QFIN presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 4/9 and a massive valuation disconnect, trading at $14.13 against a Graham Number of $64.94. While the company is facing severe earnings contraction (-40.9% YoY) and a completely bearish technical trend (0/100), its fundamental profitability remains robust with an ROE of 24.69% and a very low P/E of 2.19. The high dividend yield of 10.89% is well-supported by a low payout ratio of 23.85%, providing a significant safety buffer. The bullish assessment is based on the extreme margin of safety provided by the Price-to-Book ratio of 0.49.